Milk Protein Peptides With Angiotensin I-Converting Enzyme Inhibitory (ACEI) Activity

REFERENCES

• Abubakar, A., Tadao, S., Kitazawa, H., Kawai, Y., and Itoh, T., 1998. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion, J. Dairy Sci. 81 (1998), pp. 3131–3138.
   PubMed Web of Science ®Google Scholar
• Adessi, C., and Soto, C., 2002. Converting a peptide into a drug: strategies to improve stability and bioavailability, Curr. Med. Chem. 9 (2002), pp. 963–978.
   PubMed Web of Science ®Google Scholar
• Araujo, M. C., Melo, R. L., Cesari, M. H., and Juliano, M. A., 2000. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme, Biochemistry. 39 (2000), pp. 8519–8525.
   PubMed Web of Science ®Google Scholar
• Bitri, L., 2004. Optimization study for the production of an opioid-like preparation from bovine casein by mild acidic hydrolysis, Int. Dairy J. 14 (2004), pp. 535–539.
   Web of Science ®Google Scholar
• Chen, G.-W., Tsai, J.-S., and Pan, B.-S., 2007. Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation, Int. Dairy J. 17 (2007), pp. 641–647.
   Web of Science ®Google Scholar
• Cheung, H.-S., Feng-Lai, W., Ondetti, M. A., Sabo, E. F., and Cushman, D. W., 1980. Binding of peptide substrates and inhibitors of angiotensin-converting-enzyme, J. Biol. Chemistr. 255 (1980), pp. 401–407.
   PubMed Web of Science ®Google Scholar
• Conlin, P. R., 2001. Efficacy and safety of angiotensin receptor blockers: A review of Losartan in essential hypertension, Current Ther. Res. 62 (2001), pp. 79–91.
   Web of Science ®Google Scholar
• Conlin, P. R., Chow, D., Miller, E. R., Svetkey, L. P., Lin, P. H., Harsha, D. W., Moore, T. J., Sacks, F. M., and Appel, L. J., 2000. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial, Am. J. Hyperten. 13 (2000), pp. 949–955.
   PubMed Web of Science ®Google Scholar
• Desai, P., Coutinho, E., and Srivastava, S., 2002. Conformational diversity of T-kinin in DMSO, water and HFA, E. J. Medic. Chemistr. 37 (2002), pp. 135–146.
   PubMed Web of Science ®Google Scholar
• Deszi, L., 2000. Fibrinolytic actions of ACE inhibitors: a significant plus beyond antihypertensive therapeutic effects, Cardio. Res. 47 (2000), pp. 642–644.
   PubMed Web of Science ®Google Scholar
• Fiat, A. M., Migliore-Samour, D., Jolles, P., Drouet, L., Bal dit Sollier, C., and Caen, J., 1993. Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities, J. Dairy Sci. 76 (1993), pp. 301–10.
   PubMed Web of Science ®Google Scholar
• FitzGerald, R. J., Murray, B. A., and Walsh, D. J., 2004. Hypotensive peptides from milk proteins, J. Nutr. 134 (2004), pp. 980–988.
   PubMed Web of Science ®Google Scholar
• Fuglsang, A., Nilsson, D., and Nyborg, N., 2002. Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently cathereterized spontaneously hypertensive rats, Appl. Envir. Microbiol. 68 (2002), pp. 3566–3569.
   PubMed Web of Science ®Google Scholar
• Gardner, M. L., 1988. Gastrointestinal absorption of intact proteins, Annu. Rev. Nutr. 8 (1988), pp. 329–350.
   PubMed Web of Science ®Google Scholar
• Geerlings, A., Villar, I. C., Zarco, F. H., Sánchez, M., Vera, R., Gomez, A. Z., Boza, J., and Duarte, J., 2006. Identification and characterization of novel angiotensin-converting enzyme inhibitors obtained from goat milk, J. Dairy Sci. 89 (2006), pp. 3326–35.
   PubMed Web of Science ®Google Scholar
• Gobbetti, M., Ferranti, P., Smacchi, E., Goffredi, F., and Addeo, F., 2000. Production of angiotensin-I-converting enzyme inhibitory peptides in fermented milks started by Lactobacillus delbruekii subsp. bulgaricus SS1 and Lactococcus lactis subsp cremoris FT4, Appl. Envir. Microbiol. 66 (2000), pp. 3898–3904.
   PubMed Web of Science ®Google Scholar
• Gobbetti, M., Stepaniak, L., De Angelis, M., Corsetti, A., and Di Cagno, R., 2002. Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing, Crit. Rev. Food Sci. Nutr. 42 (2002), pp. 223–239.
   PubMed Web of Science ®Google Scholar
• Gómez-Ruiz, J. A., Ramos, M., and Recio, I., 2002. Angiotensin-converting enzyme-inhibitory peptides in manchego cheeses manufactured with different starter cultures, Int. Dairy J. 12 (2002), pp. 697–706.
   Web of Science ®Google Scholar
• Gómez-Ruiz, J. A., Recio, I., and Belloque, J., 2004. ACE-inhibitory activity and structural properties of peptide Asp-Lys–Ile–His–Pro [b- CN f(47–51)]. Study of the peptide forms synthesized by different methods, J. Agric. Food Chem. 52 (2004), pp. 6315–6319.
   PubMed Web of Science ®Google Scholar
• Hartmann, R., and Meisel, H., 2007. Food-derived peptides with biological activity: from research to food applications, Curr. Opinion Biotech. 18 (2007), pp. 163–169.
   PubMed Web of Science ®Google Scholar
• Hata, Y., Yamamoto, M., Ohni, M., Nakajima, K., Nakamura, Y., and Takano, T., 1996. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects, Am. J. Clin. Nutr. 64 (1996), pp. 767–771.
   PubMed Web of Science ®Google Scholar
• Hayes, M., Ross, R. P., Fitzgerald, G. F., and Stanton, C., 2007a. Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part I: overview, Biotechnol J. 2 (2007a), pp. 426–34.
   PubMedGoogle Scholar
• Hayes, M., Stanton, C., Fitzgerald, G. F., and Ross, R. P., 2007b. Putting microbes to work: Dairy fermentation, cell factories and bioactive peptides. Part II: Bioactive peptide functions, Biotechnol. J. 2 (2007b), pp. 435–449.
   PubMedGoogle Scholar
• Hayes, M., Stanton, C., Slattery, H., O'Sullivan, O., Hill, C., Fitzgerald, G. F., and Ross, R. P., 2007c. Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors, Appl. Environ. Microbiol. 14 (2007c), pp. 4658–4667.
   Google Scholar
• Hernández-Ledesma, B., Amigo, L., Ramos, M., and Recio, I., 2004. Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestión, J. Agric. Food Chem. 52 (2004), pp. 1504–1510.
   PubMed Web of Science ®Google Scholar
• Hernández-Ledesma, B., Miguel, M., Amigo, L., Aleixandre, M. A., and Recio, I., 2007a. Effect of simulated gastrointestinal digestion on the antihypertensive properties of synthetic β-lactoglobulin peptide sequences, J. Dairy Res. 74 (2007a), pp. 336–339.
   PubMed Web of Science ®Google Scholar
• Hernández-Ledesma, B., Quirós, A., Amigo, L., and Recio, I., 2007b. Identification of bioactive peptides after digestion of human milk and infant formula with pepsin and pancreatin, Int. Dairy J. 17 (2007b), pp. 42–49.
   Web of Science ®Google Scholar
• Hernández-Ledesma, B., Miralles, B., Amigo, L., Ramos, M., and Recio, I., 2005. Identification of antioxidant and ACE-inhibitory peptides in fermented milk, J. Sci. Food Agric. 85 (2005), pp. 1041–1048.
   Web of Science ®Google Scholar
• Hernández-Ledesma, B., Ramos, M., Recio, I., and Amigo, L., 2006. Effect of β -lactoglobulin hydrolysis with thermolysin under denaturing temperatures on the release of bioactive peptides, J. Chromatogr. 1116 (2006), pp. 31–37.
   PubMed Web of Science ®Google Scholar
• Hernández-Ledesma, B., Recio, I., Ramos, M., and Amigo, L., 2002. Preparation of ovine and caprine b-lactoglobulin hydrolysates with ACE-inhibitory activity. Identification of active peptides from caprine b-lactoglobulin hydrolysed with thermolysin, Int. Dairy J. 12 (2002), pp. 805–812.
   Web of Science ®Google Scholar
• Hirota, T., Ohki, K., Kawagishi, R., Kajimoto, Y., Mizuno, S., Nakamura, Y., and Kitakaze, M., 2007. Casein hydrolysate containing the antihypertensive tripeptides val-pro-pro and ile-pro-pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme, Hipertens. Res. 30 (2007), p. 6.
   Web of Science ®Google Scholar
• Ishikawa-Takata, K., Ohta, T., and Tanaka, H., 2003. How much exercise is required to reduce blood pressure in essential hypertensives: a dose-response study, Am. J. Hyperten. 16 (2003), pp. 629–633.
   PubMed Web of Science ®Google Scholar
• Itakura, H., Ikemoto, S., Terada, S., and Kondo, K., 2001. The effect of sour milk on blood pressure in untreated hypertensive and normotensive subjects, J. Jpn. Soc. Nutr. Food Sci. 23 (2001), pp. 26–31.
   Google Scholar
• Jauhiainen, T., and Korpela, R., 2007. Milk peptides and blood pressure, J. Nutr. 137 (2007), pp. 825–829.
   PubMed Web of Science ®Google Scholar
• Jauhiainen, T., Collin, M., Narva, M., Poussa, T., and Korpela, R., 2005a. Effect of long term intake of milk peptides and minerals on blood pressure and arterial function in spontaneously hypertensive rats, Milchwissenschaft. 60 (2005a), pp. 358–363, .
   Web of Science ®Google Scholar
• Jauhiainen, T., Vapaatalo, H., Poussa, T., Kyronpalo, S., Rasmussen, M., and Korpela, R., 2005b. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24h ambulatory blood preassure measurement, Am J Hypertens. 18 (2005b), pp. 1600–1605.
   PubMed Web of Science ®Google Scholar
• Kajimoto, O., Kotaro, A., Hirata, H., Takahashi, R., and Nakamura, Y., 2001a. Hipotensive effects of the tablets containing “Lactotripeptides” (VPP, IPP), J. Nutr. Food. 4 (2001a), pp. 51–61.
   Google Scholar
• Kajimoto, O., Kurosaki, T., Mizutani, J., Ikeda, N., Kaneko, K., Aihara, K., Yabune, M., and Nakamura, Y., 2002. Antihypertensive effects of liquid yogurts containing “lactotripeptides (VPP, IPP)” in mild hypertensive subjects, J. Nutr. Food. 5 (2002), pp. 55–66.
   Google Scholar
• Kajimoto, O., Nakamura, Y., Yada, H., Moriguchi, S., Hirata, H., and Takahashi, T., 2001b. Hypotensive effects of sour milk in subjects with mild or moderate hypertension, J. Jpn. Soc. Nutr. Food Sci. 54 (2001b), pp. 347–354.
   Google Scholar
• Kilara, A., and Panyam, D., 2003. Peptides from milk proteins and their properties, Crit. Rev. Food Sci. Nutr. 43 (2003), pp. 607–633.
   PubMed Web of Science ®Google Scholar
• Kitts, D. D., and Weiler, K., 2003. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery, Curr. Pharmacol. Design. 9 (2003), pp. 1309–1323.
   PubMed Web of Science ®Google Scholar
• Korhonen, H., and Pihlanto-Leppala, A., 2006. Food-derived bioactive peptides: opportunities for designing future foods, Curr. Pharm. Des. 9 (2006), pp. 1297–1308.
   Google Scholar
• Korhonen, H., and Pihlanto-Leppala, A., 2007. Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum, Curr. Pharm. Des. 13 (2007), pp. 829–43.
   PubMed Web of Science ®Google Scholar
• Korhonen, H., and Pihlanto, A., 2003a. Bioactive peptides: Novel applications for milk proteins, Appl. Biotechnol. Food Sci. Policy. 1 (2003a), pp. 133–144.
   Google Scholar
• Korhonen, H., and Pihlanto, A., 2003b. Food-derived bioactive peptides–Opportunities for designing future foods, Curr. Pharm. Des. 9 (2003b), pp. 1297–1308.
   PubMed Web of Science ®Google Scholar
• Leclerc, P. -L., Gauthier, S. F., Bachelard, H., Santure, M., and Roy, D., 2002. Antihypertensive activity of casein-enriched milk fermented by, Lactobacillus helveticus. Int. Dairy J. 12 (2002), pp. 995–1004.
   Web of Science ®Google Scholar
• Lee, Y., Skurk, T., Hennig, M., and Hauner, H., 2007. Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hipertension, Eur. J. Nutr. 46 (2007), pp. 21–27.
   PubMed Web of Science ®Google Scholar
• Li, E. W. Y., and Mine, Y., 2004. Immunoenhancing effects of bovine glycomacropeptide and its derivatives on the proliferative response and phagocytic activities of human macrophagelike cells, U937, J. Agric. Food Chem. 52 (2004), pp. 2704–2708.
   PubMed Web of Science ®Google Scholar
• Li, G. H., Liu, H., Shi, Y. H., and Le, G. W., 2005. Direct spectrophotometric measurement of angiotensin I-converting enzyme inhibitory activity for screening bioactive peptides, J. Pharm. Biomed. Anal. 37 (2005), pp. 219–224.
   PubMed Web of Science ®Google Scholar
• Liu, D., Sun, H., Zhang, K., and Li, S., 2007. High-level expression of milk-derived antihypertensive peptide in Escherichia coli and its bioactivity, J. Agric. Food Chem. 55 (2007), pp. 5109–5112.
   PubMed Web of Science ®Google Scholar
• López Expósito, I., and Recio, I., 2006. Antibacterial activity of peptides and folding variants from milk proteins, Int. Dairy J. 16 (2006), pp. 1294–1305.
   Web of Science ®Google Scholar
• López-Fandiño, R., Otte, J., and Van Camp, J., 2006. Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity, Int. Dairy J. 16 (2006), pp. 1277–1293.
   Web of Science ®Google Scholar
• Losacco, M., Gallerani, R., Gobbetti, M., Minervini, F., and De Leo, F., 2007. Production of active angiotensin-I converting enzyme inhibitory peptides derived from bovine beta-casein by recombinant DNA technologies, Biotechnol. J. 2 (2007), pp. 1425–34.
   PubMedGoogle Scholar
• Maeno, M., Yamamoto, N., and Takano, T., 1996. Identification of antihypertensive peptides from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790, J. Dairy Sci. 73 (1996), pp. 1316–1321.
   Google Scholar
• Malkoski, M., Dashper, S. G., O'Brien–Simpson, N. -M., Talbo, G. H., Macris, M., Cross, K. J., and Reynolds, E. C., 2001. Kappacin, a novel antibacterial peptide from bovine milk, Antimicrobial A. Chemot. 45 (2001), pp. 2309–2315.
   PubMed Web of Science ®Google Scholar
• Manso, M. A., and López-Fandino, R., 2004. κ-Casein macropeptides from cheese whey: Physicochemical, biological, nutritional, and technological features for possible uses, Food Rev. Int. 20 (2004), pp. 329–355.
   Web of Science ®Google Scholar
• Matar, C., Valdez, J. C., Medina, M., Rachid, M., and Perdigón, G., 2001. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant, J. Dairy Res. 68 (2001), pp. 601–609.
   PubMed Web of Science ®Google Scholar
• McCann, K. B., Shiell, B. J., Michalski, W. P., Lee, A., Wan, J., and Roginski, H., 2005. Isolation and characterization of antibacterial peptides derived from the f(164–207) region of bovine as2-casein, Int. Dairy J. 15 (2005), pp. 133–143.
   Web of Science ®Google Scholar
• McCann, K. B., Shiell, B. J., Michalski, W. P., Lee, A., Wan, J., and Roginski, H., 2006. Isolation and characterization of a novel antibacterial peptide from bovine as1-casein, Int. Dairy J. 16 (2006), pp. 316–323.
   Web of Science ®Google Scholar
• Meisel, H., and Fitz Gerald, R. J., 2003. Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects, Curr. Pharm. Des. 9 (2003), pp. 1289–95.
   PubMed Web of Science ®Google Scholar
• Meisel, H., 2004. Multifunctional peptides encrypted in milk proteins, BioFactor. 21 (2004), pp. 55–61.
   PubMed Web of Science ®Google Scholar
• Meisel, H., 2005. Biochemical properties of peptides encrypted in bovine milk proteins, Curr. Med. Chem. 12 (2005), pp. 1905–1919.
   PubMed Web of Science ®Google Scholar
• Meisel, H., and Bockelmann, W., 1999. Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties, Ant. Van Leeuwen. 76 (1999), pp. 207–215.
   PubMed Web of Science ®Google Scholar
• Meisel, H., Bernard, H., Fairweather-Tait, S., FitzGerald, R. J., Hartmann, R., Lane, C. N., McDonagh, D., Teucher, B., and Wal, J. M., 2003. Detection of caseinophosphopeptides in the distal ileostomy fluid of human subjects, Brit. J. Nutr. 89 (2003), pp. 351–358.
   PubMed Web of Science ®Google Scholar
• Mellander, O., 1950. The physiological importance of the casein phosphopeptide calcium salts. II. Peroral calcium dosage of infants, Acta Soc. Med. Ups. 55 (1950), pp. 247–255.
   PubMedGoogle Scholar
• Miguel, M., Manso, M., Aleixandre, A., Alonso, M. J., Salaices, M., and López-Fandiño, R., 2007. Vascular effects, angiotensin I- converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from egg white, J. Agric. Food Chem. 5 (2007), pp. 10615–21.
   Google Scholar
• Miguel, M., Muguerza, B., Sánchez, E., Delgado, M. A., Recio, I., and Ramos, M., 2005. Long-term blood pressure-lowering effect of milk fermented by Enterococcus faecalis CECT 5728 in spontaneously hypertensive rats, Brit. J. Nutr. 93 (2005), pp. 1–9.
   PubMedGoogle Scholar
• Minervini, F., Algaron, F., Rizzello, C. G. P., Fox, F., Monnet, V., and Gobbetti, M., 2003. Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species, Appl. Envir. Microbiol. 69 (2003), pp. 5297–5305.
   PubMed Web of Science ®Google Scholar
• Mizuno, S., Matsuura, K., Gotou, T., Nishimura, S., Kajimoto, O., and Yabune, M., 2005. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension, Brit. J. Nutr. 94 (2005), pp. 84–91.
   PubMed Web of Science ®Google Scholar
• Mizushima, S., Ohshige, K., Watanabe, J., Kimura, M., Kadowaki, T., and Nakamura, Y., 2004. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men, Am. J. Hypertens. 17 (2004), pp. 701–706.
   PubMed Web of Science ®Google Scholar
• Muguerza, B., Ramos, M., Sánchez, E., Manso, M. A., Miguel, M., Aleixandre, A., Delgado, M. A., and Recio, I., 2006. Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk, Int. Dairy J. 16 (2006), pp. 61–69.
   Web of Science ®Google Scholar
• Mullally, M. M., Meisel, H., and Fitzgerald, R. J., 1996. Synthetic peptides corresponding to α -lactalbumin and β -lactoglobulin sequences with angiotensin-I- converting enzyme inhibitory activity, Biol. Chem. Hoppe-Seyler. 377 (1996), pp. 259–260.
   PubMed Web of Science ®Google Scholar
• Mullally, M. M., Meisel, H., and Fitzgerald, R. J., 1997. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a triptic fragment of bovine β -lactoglobulin, FEBS Letters. 402 (1997), pp. 99–101.
   PubMed Web of Science ®Google Scholar
• Murakami, M., Tonouchi, H., Takahashi, R., Kitazawa, H., Kawai, Y., Negishi, H., and Saito, T., 2004. Structural analysis of a new anti-hypertensive peptide (β-Lactosin B) isolated from a commercial whey product, J. Dairy Sci. 87 (2004), pp. 1967–1974.
   PubMed Web of Science ®Google Scholar
• Murray, B. A., and Fitz Gerald, R. J., 2007. Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production, Curr Pharm Des. 13 (2007), pp. 773–91.
   PubMed Web of Science ®Google Scholar
• Murray, B. A., Walsh, D. J., and FitzGerald, R. J., 2004. Modification of the furanacryloyl-L-phenylalanylglycylglycine assay for determination of angiotensin-I-converting enzyme inhibitory activity, J. Biochem. Biophy. Methods 59 (2004), pp. 127–137, .
   PubMedGoogle Scholar
• Nakamura, Y., Kajimoto, O., Kaneko, K., Aihara, K., Mizutani, J., Ikeda, N., Nishimura, A., and Kajimoto, Y., 2004. Effects of the liquid yogurts containing “lactotripeptide (VPP, IPP)” on high-normal blood pressure, J. Nutr. Food. 7 (2004), pp. 123–137.
   Google Scholar
• Nakamura, Y., Yamamoto, N., Sakai, K., and Takano, T., 1995a. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme, J. Dairy Sci. 78 (1995a), pp. 1253–7.
   PubMed Web of Science ®Google Scholar
• Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Vamazak, S., and Takano, T., 1995b. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk, J. Dairy Sci. 78 (1995b), pp. 777–783.
   PubMed Web of Science ®Google Scholar
• Nurminen, M. L., Sipola, M., Kaarto, H., Pihlanto-Leppala, A., Piilola, K., Korpela, R., Tossavainen, O., Coronen, H., and Vapaatalo, H., 2000. Alpha-lactorphin lowes blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats, Life Sci. 66 (2000), pp. 1535–43.
   PubMed Web of Science ®Google Scholar
• Papadimitriou, C. G., Vafopoulou-Mastrojiannaki, A., Vieira, S., Gomes, A. -M., Xavier, F., and Alichanidis, E., 2007. Identification of peptides in traditional and probiotic sheep milk yoghurt with angiotensin I- converting enzyme (ACE) inhibitory activity, F. chemistry. 105 (2007), pp. 647–656.
   Web of Science ®Google Scholar
• Pihlanto-Leppälä, A., 2001. Bioactive peptides derived from bovine whey proteins: opioid and ace-inhibitory peptides, T. Food Tech. 11 (2001), pp. 347–356.
   Web of Science ®Google Scholar
• Pihlanto-Leppälä, A., Koskinen, P., Piilola, K., Tupasela, T., and Korhonen, H., 2000. Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides, J. Dairy Res. 67 (2000), pp. 53–64.
   PubMed Web of Science ®Google Scholar
• Pihlanto-Leppala, A., Rokka, T., and Korhonen, H., 1998. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins, Int. Dairy J. 8 (1998), pp. 325–331.
   Web of Science ®Google Scholar
• Pins, J. J., and Keenan, J. M., 2003. The antihypertensive effects of a hydrolyzed whey protein isolate supplement (Biozate 1): A pilot study, FASEB J. 17 (2003), p. 1110.
   PubMed Web of Science ®Google Scholar
• Pins, J. J., and Keenan, J. M., 2002. The antihypertensive effect of a hydrolysed whey protein isolate supplement (Biozate 1), Cardiov. Drugs Therapy. 16 (2002), p. S68.
   Google Scholar
• Quirós, A., Ramos, M., Muguerza, B., Delgado, M. A., Miguel, M., and Aleixandre, A., 2007. Identification of novel antihypertensive peptides in milk fermented with Enterococus faecalis, Int. Dairy J. 17 (2007), pp. 33–41.
   Web of Science ®Google Scholar
• Quirós, A., Hernández-Ledesma, B., Ramos, M., Amigo, L., and Recio, I., 2005. Angiotensin-convertig enzyme inhibitory activity of peptides derived from caprine kefir, J. Dairy Sci. 88 (2005), pp. 3480–3487.
   PubMed Web of Science ®Google Scholar
• Riordan, J. F., 2003. Angiotensin-I-converting enzyme and its relatives, Genome Biol. 4 (2003), p. 225.
   PubMed Web of Science ®Google Scholar
• Robert, P. R., and Zaloga, G. P., 1994. Dietary bioactive peptides, New Horizons. 2 (1994), pp. 237–243.
   PubMedGoogle Scholar
• Roufik, S., Gauthier, S. F., and Turgeon, S. L., 2006. In vitro digestibility of bioactive peptides derived from bovine b-lactoglobulin, Int. Dairy J. 16 (2006), pp. 294–302.
   Web of Science ®Google Scholar
• Saito, T., Nakamura, T., Kitazawa, H., Kawai, Y., and Itoh, T., 2000. Isolation and structural analysis of antihypertensive peptides that exist naturally in gouda cheese, J. Dairy Sci. 83 (2000), pp. 1434–1440.
   PubMed Web of Science ®Google Scholar
• Seppo, L., Jauhiainen, T., Poussa, T., and Korpela, R., 2003. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects, Am. J. Clin. Nutr. 77 (2003), pp. 326–330.
   PubMed Web of Science ®Google Scholar
• Seppo, L., Kerojoki, O., Suomalainen, T., and Korpela, R., 2002. The effect of a Lactobacillus helveticus LBK-16H fermented milk on hypertension: A pilot study on humans, Milchwissenschaft. 57 (2002), pp. 124–127.
   Web of Science ®Google Scholar
• Séverin, S., and Wenshui, X., 2005. Milk biologically active components as nutraceuticals: Review, Crit. Rev. Food Sci. Nutr. 45 (2005), pp. 645–656.
   PubMed Web of Science ®Google Scholar
• Sipola, M., Finckenberg, P., Santisteban, J., Korpela, R., Vapaatalo, H., and Nurminen, M.-L., 2001. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats, J. Physiol. Pharmacol. 52 (2001), pp. 745–754.
   PubMed Web of Science ®Google Scholar
• Sipola, M., Finckenberg, P., Santisteban, J., Korpela, R., Vapaatalo, H., and Nurminen, M. L., 2002. Effect of long-term intake of milk products on blood pressure in hypertensive rats, J. Dairy Res. 69 (2002), pp. 103–11.
   PubMed Web of Science ®Google Scholar
• Steidler, L., and Rottiers, P., 2006. Therapeutic drug delivery by genetically modified Lactococcus lactis, Ann. N. Y. Acad. Sci. 1072 (2006), pp. 176–186.
   PubMed Web of Science ®Google Scholar
• Sugai, R., 1998. ACE inhibitors and functional foods, Bulletin of the IDF. 336 (1998), pp. 17–20.
   Google Scholar
• Tauzin, J., Miclo, L., and Gaillard, J. L., 2002. Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine KS2-casein, FEBS Letters 531 (2002), pp. 369–374.
   PubMed Web of Science ®Google Scholar
• Townsend, R. R., Mc Fadden, C. B., Ford, V., and Cadée, J. A., 2004. A randomized, double-blind, placebo-controlled trial of casein protein hydrolysaet (C12 peptide) in human essential hipertensión, Am. J. Hyperten. 17 (2004), pp. 1056–1058.
   PubMed Web of Science ®Google Scholar
• Tsai, J. -S., Chen, T. -J., Sun Pan, B., Gong, S. -D., and Chung, M. -Y., 2008. Antihypertensive effect of bioactive peptides produced by protease-facilitated lactic acid fermentation of milk, Food Chem. 106 (2008), pp. 552–558.
   Web of Science ®Google Scholar
• Tuomilehto, J., Lindstrom, J., Hyyrynen, J., Korpela, R., Karhunen, M. L., and Mikkola, L., 2004. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension, J. Hum. Hypertens. 18 (2004), pp. 795–802.
   PubMed Web of Science ®Google Scholar
• Unger, T., 2002. The role of the renin-angiotensin system in the development of cardiovascular disease, Am. J. Cardiol. 89 (2002), pp. 3–9.
   PubMed Web of Science ®Google Scholar
• Vermeirssen, V., Van Camp, J., and Verstraete, W., 2004. Bioavailability of angiotensin I converting enzyme inhibitory peptides, Brit. J. Nutr. 92 (2004), pp. 357–366.
   PubMed Web of Science ®Google Scholar
• Vermeirssen, V., Van Camp, J., and Verstraete, W., 2002. Optimization and validation of an angiotensin-converting enzyme inhibition assay for the screening of bioactive peptides, J. Biochem. Biophy. Methods 51 (2002), pp. 75–87.
   PubMedGoogle Scholar
• Vermeirssen, V., Van Camp, J., Decroos, K., Van Wijmelbeke, V., and Verstraete, W., 2003. The impact of fermentation and in vitro digestion on the formation of angiotensin-I-converting enzyme inhibitory activity from pea and whey protein, J. Dairy Sci. 86 (2003), pp. 429–438.
   PubMed Web of Science ®Google Scholar
• Weber, M. A., 2001. Vasopeptidase inhibitors, The Lancet 358 (2001), pp. 1525–1532.
   PubMed Web of Science ®Google Scholar
• Witt, K. A., Sillespie, T. T., Huber, T. D., and Egleton, R. D., 2001. Peptide drug modifications to enhance bioavailability and blood–brain barrier permeability, Peptides. 22 (2001), pp. 2329–2343.
   PubMed Web of Science ®Google Scholar
• Yamamoto, N., and Takano, T., 1999. Antihypertensive peptides derived from milk proteins, Nahrung. 43 (1999), pp. 159–164.
   PubMedGoogle Scholar
• Yamamoto, N., Akino, A., and Takano, T., 1994. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790, J. Dairy Sci. 77 (1994), pp. 917–922.
   PubMed Web of Science ®Google Scholar
• Yamamoto, N., Maeno, M., and Takano, T., 1999. Purification and characterization of an antihypertensive peptide from yoghurt-like product fermented by Lactobacillus helveticus CPN4, J. Dairy Sci. 82 (1999), pp. 1388–1393.
   PubMed Web of Science ®Google Scholar